The Right Approach To Regenerative Medicine

RHM Medical Advisors

RHM COVID-19

Antibody
Test - $159

Antibodies have been found to be a highly sensitive biomarkers in infectious disease diagnosis, previous studies on SARS, MERS and more recently the ones on SARS-CoV2 have shown IgM antibodies to appear about the 3rd day from infection and IgG antibodies appear after 8 days. Profiling an individual’s antibody response is the only way to determine infections with few or no symptoms. Vibrant COVID-19 Ab assay is an in-vitro diagnostic test intended for the quantitative and qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human serum collected from individuals who are suspected of COVID-19.

Regulatory Statement

The US-based labs that RHM contracts with are certified under the Clinical Laboratory Improvements Amendment of 1988 (CLIA ’88), accredited by the College of American Pathologists (CAP), and has over 5 years’ experience designing, validating, and performing Laboratory Developed Tests (LDTs) for physicians and patients. Maintaining accreditation through the CAP requires that LDTs are validated to standards exceeding those listed in CLIA ’88 which defines the minimum standards that must be met in order to perform LDTs for diagnostic purposes.

Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals. Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status. Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E. Not for the screening of donated blood.

RHM COVID-19 Test

Schedule your COVID-19 Test with an RHM Advisor near you